These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 16711397)

  • 1. [Dilemmas of the pharmacist, 7th edition of Hungarian National Formulary in practice].
    Pál S
    Acta Pharm Hung; 2005; 75(4):199-203. PubMed ID: 16711397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pricing of multiple dosage prescription medications: an analysis of the Ontario Drug Benefit Formulary.
    Lexchin J
    Health Policy; 2009 Jul; 91(2):142-7. PubMed ID: 19147251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Formulae Normales Editio IV: new edition of the Hungarian formulary].
    ELLO I
    Pharm Zentralhalle Dtschl; 1961 Mar; 100():112-3. PubMed ID: 13726523
    [No Abstract]   [Full Text] [Related]  

  • 4. Legal implications of the pharmacist's expanded clinical roles: a challenge to the clinical pharmacist's competencies.
    Moore RC; Mikeal RL; Brewer BF; Burton SF
    Contemp Pharm Pract; 1979; 2(3):132-5. PubMed ID: 10297530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulary revision: eliciting the opinions of users.
    McGavock H; Wilson-Davis K; McGavock SA
    Br J Gen Pract; 1996 Jul; 46(408):419-21. PubMed ID: 8776914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quo vadis, Pharmacopoeia Hungarica?].
    Kószeginé SH; Török I; Lipták J; Paál T
    Acta Pharm Hung; 2001; 71(1):99-103. PubMed ID: 11769103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Product selection: community formularies and legal aspects. The pharmacist's responsibility in product selection.
    Kanig JL
    Am J Pharm Sci Support Public Health; 1972; 144(5):133-8. PubMed ID: 4641165
    [No Abstract]   [Full Text] [Related]  

  • 8. [Presentation of 2 formularies: "Formulary of Clinical Therapeutics" (XV edition) and "Formulary of Emergencies" (XVII edition].
    Lorenzo Velázquez B
    An R Acad Nac Med (Madr); 1981; 98(2):211-26. PubMed ID: 7027821
    [No Abstract]   [Full Text] [Related]  

  • 9. [Proposals on analytic methods for Italian National Formulary preparations. Bismuth antacid tablets].
    De Santis A; Re Garbagnati V
    Boll Chim Farm; 1967 Mar; 106(3):193-7. PubMed ID: 5615989
    [No Abstract]   [Full Text] [Related]  

  • 10. Basic principles of pharmaceutical science in Ayurvĕda.
    Subhose V; Srinivas P; Narayana A
    Bull Indian Inst Hist Med Hyderabad; 2005; 35(2):83-92. PubMed ID: 17333665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE NATIONAL FORMULARY AND THE PRACTICING PHARMACIST.
    FELDMANN EG
    Am J Pharm Sci Support Public Health; 1965; 137():50-6. PubMed ID: 14325255
    [No Abstract]   [Full Text] [Related]  

  • 12. The New Jersey Formulary--Sixth Edition.
    ROWE TS; VARRIANO JL
    J Med Soc N J; 1951 Apr; 48(4):151-2. PubMed ID: 14824866
    [No Abstract]   [Full Text] [Related]  

  • 13. Superior hospital formularies: a critical analysis.
    Rucker TD
    Hosp Pharm; 1982 Sep; 17(9):465-71, 474-5, 477-9 passim. PubMed ID: 10257551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incentive formularies and changes in prescription drug spending.
    Landon BE; Rosenthal MB; Normand SL; Spettell C; Lessler A; Underwood HR; Newhouse JP
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):360-9. PubMed ID: 17567237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulary implications of management of pulmonary arterial Hypertension: Part II--Payer and provider perspectives on new therapeutic options.
    Feldman J; Berenbeim D
    Manag Care Interface; 2006 Dec; 19(12):20-6, 49. PubMed ID: 17274478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulary implications of management of pulmonary arterial hypertension: Part I--An overview of existing and new pharmacological treatment options.
    Feldman J; Berenbeim D
    Manag Care Interface; 2006 Nov; 19(11):51-60, 67. PubMed ID: 17137242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of health-related quality of life information in managed care formulary decision-making.
    Wu WK; Sause RB; Zacker C
    Res Social Adm Pharm; 2005 Dec; 1(4):579-98. PubMed ID: 17138497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The new drug formulary (NDF) of the German drug codex].
    Reimann H
    Pharm Unserer Zeit; 2010 Jul; 39(4):274-9. PubMed ID: 20589798
    [No Abstract]   [Full Text] [Related]  

  • 19. Some of the pharmaceutical necessities of the new National Formulary.
    GREEN MW
    Bull Am Pharm Assoc; 1946; 14():97-108. PubMed ID: 20985303
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
    Malone DC; Abarca J; Skrepnek GH; Murphy JE; Armstrong EP; Grizzle AJ; Rehfeld RA; Woosley RL
    Med Care; 2007 May; 45(5):456-62. PubMed ID: 17446832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.